Information Provided By:
Fly News Breaks for January 3, 2020
HUM
Jan 3, 2020 | 06:37 EDT
JPMorgan analyst Gary Taylor raised his price target on Humana to $448 and kept his Overweight rating, saying the stock represents a "nearly pure-play" on the "strong" organic industry enrollment growth in Medicare Advantage. The analyst expects the company to gain further market share in 2021 while also forecasting managed care valuations to expand this year as concerns regarding healthcare reform continue to subside.